LZAGF
Price
$670.67
Change
-$7.78 (-1.15%)
Updated
Feb 3 closing price
Capitalization
46.98B
Intraday BUY SELL Signals
LZAGY
Price
$67.05
Change
-$0.28 (-0.42%)
Updated
Feb 3 closing price
Capitalization
46.98B
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LZAGF vs LZAGY

Header iconLZAGF vs LZAGY Comparison
Open Charts LZAGF vs LZAGYBanner chart's image
Lonza Group AG
Price$670.67
Change-$7.78 (-1.15%)
Volume$72
Capitalization46.98B
Lonza Group AG
Price$67.05
Change-$0.28 (-0.42%)
Volume$38.85K
Capitalization46.98B
LZAGF vs LZAGY Comparison Chart in %
LZAGF
Daily Signal:
Gain/Loss:
LZAGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LZAGF vs. LZAGY commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZAGF is a Hold and LZAGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LZAGF: $670.67 vs. LZAGY: $67.05)
Brand notoriety: LZAGF and LZAGY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LZAGF: 8% vs. LZAGY: 54%
Market capitalization -- LZAGF: $46.98B vs. LZAGY: $46.98B
LZAGF [@Medical Specialties] is valued at $46.98B. LZAGY’s [@Medical Specialties] market capitalization is $46.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LZAGF’s FA Score shows that 1 FA rating(s) are green whileLZAGY’s FA Score has 1 green FA rating(s).

  • LZAGF’s FA Score: 1 green, 4 red.
  • LZAGY’s FA Score: 1 green, 4 red.
According to our system of comparison, both LZAGF and LZAGY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LZAGF’s TA Score shows that 5 TA indicator(s) are bullish while LZAGY’s TA Score has 5 bullish TA indicator(s).

  • LZAGF’s TA Score: 5 bullish, 5 bearish.
  • LZAGY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both LZAGF and LZAGY are a good buy in the short-term.

Price Growth

LZAGF (@Medical Specialties) experienced а -9.78% price change this week, while LZAGY (@Medical Specialties) price change was -7.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.33%. For the same industry, the average monthly price growth was -0.33%, and the average quarterly price growth was +22.90%.

Reported Earning Dates

LZAGY is expected to report earnings on Apr 16, 2026.

Industries' Descriptions

@Medical Specialties (-4.33% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LZAGF($47B) and LZAGY($47B) have the same market capitalization . LZAGF (40.20) and LZAGY (40.19) have similar P/E ratio . LZAGY YTD gains are higher at: -0.208 vs. LZAGF (-1.438). LZAGF (1.05B) and LZAGY (1.05B) have comparable annual earnings (EBITDA) . LZAGF (907M) and LZAGY (907M) have equal amount of cash in the bank . LZAGF (4.61B) and LZAGY (4.61B) have identical debt. LZAGF (7.09B) and LZAGY (7.09B) have equivalent revenues.
LZAGFLZAGYLZAGF / LZAGY
Capitalization47B47B100%
EBITDA1.05B1.05B100%
Gain YTD-1.438-0.208690%
P/E Ratio40.2040.19100%
Revenue7.09B7.09B100%
Total Cash907M907M100%
Total Debt4.61B4.61B100%
FUNDAMENTALS RATINGS
LZAGF vs LZAGY: Fundamental Ratings
LZAGF
LZAGY
OUTLOOK RATING
1..100
5056
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
9592
SMR RATING
1..100
9292
PRICE GROWTH RATING
1..100
5656
P/E GROWTH RATING
1..100
9090
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (18) in the null industry is in the same range as LZAGF (19). This means that LZAGY’s stock grew similarly to LZAGF’s over the last 12 months.

LZAGY's Profit vs Risk Rating (92) in the null industry is in the same range as LZAGF (95). This means that LZAGY’s stock grew similarly to LZAGF’s over the last 12 months.

LZAGY's SMR Rating (92) in the null industry is in the same range as LZAGF (92). This means that LZAGY’s stock grew similarly to LZAGF’s over the last 12 months.

LZAGY's Price Growth Rating (56) in the null industry is in the same range as LZAGF (56). This means that LZAGY’s stock grew similarly to LZAGF’s over the last 12 months.

LZAGY's P/E Growth Rating (90) in the null industry is in the same range as LZAGF (90). This means that LZAGY’s stock grew similarly to LZAGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LZAGFLZAGY
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 15 days ago
58%
Bullish Trend 24 days ago
55%
Declines
ODDS (%)
Bearish Trend 22 days ago
61%
Bearish Trend 6 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
LZAGF
Daily Signal:
Gain/Loss:
LZAGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESLA1.170.08
+7.34%
Estrella Immunopharma
BYND0.760.02
+3.03%
Beyond Meat
AUR4.120.05
+1.23%
Aurora Innovation
BPYPM15.85-0.01
-0.03%
Brookfield Property Partners LP
ELVN27.60-0.57
-2.02%
Enliven Therapeutics

LZAGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGF has been loosely correlated with LZAGY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGF jumps, then LZAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGF
1D Price
Change %
LZAGF100%
-2.11%
LZAGY - LZAGF
61%
Loosely correlated
-1.47%
SAUHF - LZAGF
30%
Poorly correlated
-4.05%
TCHBF - LZAGF
28%
Poorly correlated
N/A
SAUHY - LZAGF
28%
Poorly correlated
-2.68%
SOAGY - LZAGF
26%
Poorly correlated
+7.02%
More

LZAGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGY has been loosely correlated with LZAGF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGY jumps, then LZAGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGY
1D Price
Change %
LZAGY100%
-1.47%
LZAGF - LZAGY
62%
Loosely correlated
-2.11%
TMO - LZAGY
42%
Loosely correlated
-2.01%
SOAGY - LZAGY
41%
Loosely correlated
+7.02%
CRL - LZAGY
37%
Loosely correlated
-5.54%
DHR - LZAGY
36%
Loosely correlated
-3.05%
More